Patent · US Active

Treatment method and product for uterine fibroids using purified collagenase

US9744138B2 · kind B2 · utility

2Cited by
5References
31Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 14, 2014
Grant dateAug 29, 2017
Priority date
Expiry dateMar 14, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.